Rheumatic symptoms and serological abnormalities induced by oral contraceptives.
D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D009504:Neutrophils; D010689:Phlebitis / Q000139:chemically induced; D011928:Raynaud Disease / Q000139:chemically induced; D012216:Rheumatic Diseases / Q000139:chemically induced*; D012217:Rheumatoid Factor / Q000032:analysis*; D013924:Thrombophlebitis / Q000150:complications; D005719:gamma-Globulins / Q000032:analysis*
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D003276:Contraceptives, Oral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D005719:gamma-Globulins; D012217:Rheumatoid Factor